Atlas Trials

Dyskinesia, Drug-Induced

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Dyskinesia, Drug-Induced

RecordFirmDate
Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy (NCT05116813)Addex Pharma S.A.2021-10-25
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy (NCT04857359)Addex Pharma S.A.2021-08-06
Safinamide for Levodopa-induced Dyskinesia (PD-LID) (NCT03987750)Zambon SpA2019-10-01
Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors (NCT04064294)VA Office of Research and Development2019-08-22
Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease (NCT03354455)Danish Research Centre for Magnetic Resonance2017-08-01
Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias (NCT01173731)Novartis Pharmaceuticals2010-10-01
Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia (NCT00837707)Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan2008-06-01
Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628) (NCT00686699)Merck Sharp & Dohme LLC2006-07-10
Movement Disorders Caused by Antipsychotic Drugs in Older Patients (NCT00255879)University of California, San Diego1999-01-01

Track Dyskinesia, Drug-Induced automatically

Every clearance here is in the API, with alerts when new ones post.